415 related articles for article (PubMed ID: 20923554)
1. RARα1 control of mammary gland ductal morphogenesis and wnt1-tumorigenesis.
Cohn E; Ossowski L; Bertran S; Marzan C; Farias EF
Breast Cancer Res; 2010; 12(5):R79. PubMed ID: 20923554
[TBL] [Abstract][Full Text] [Related]
2. Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity.
Cicchini M; Chakrabarti R; Kongara S; Price S; Nahar R; Lozy F; Zhong H; Vazquez A; Kang Y; Karantza V
Autophagy; 2014; 10(11):2036-52. PubMed ID: 25483966
[TBL] [Abstract][Full Text] [Related]
3. Chromatin effector Pygo2 regulates mammary tumor initiation and heterogeneity in MMTV-Wnt1 mice.
Watanabe K; Fallahi M; Dai X
Oncogene; 2014 Jan; 33(5):632-42. PubMed ID: 23334328
[TBL] [Abstract][Full Text] [Related]
4. Cooperative signaling between Wnt1 and integrin-linked kinase induces accelerated breast tumor development.
Oloumi A; Maidan M; Lock FE; Tearle H; McKinney S; Muller WJ; Aparicio SA; Dedhar S
Breast Cancer Res; 2010; 12(3):R38. PubMed ID: 20565980
[TBL] [Abstract][Full Text] [Related]
5. Loss of Limb-Bud-and-Heart (LBH) attenuates mammary hyperplasia and tumor development in MMTV-Wnt1 transgenic mice.
Ashad-Bishop K; Garikapati K; Lindley LE; Jorda M; Briegel KJ
Biochem Biophys Res Commun; 2019 Jan; 508(2):536-542. PubMed ID: 30509497
[TBL] [Abstract][Full Text] [Related]
6. The Wnt signaling receptor Lrp5 is required for mammary ductal stem cell activity and Wnt1-induced tumorigenesis.
Lindvall C; Evans NC; Zylstra CR; Li Y; Alexander CM; Williams BO
J Biol Chem; 2006 Nov; 281(46):35081-7. PubMed ID: 16973609
[TBL] [Abstract][Full Text] [Related]
7. Dietary suppression of the mammary CD29(hi)CD24(+) epithelial subpopulation and its cytokine/chemokine transcriptional signatures modifies mammary tumor risk in MMTV-Wnt1 transgenic mice.
Rahal OM; Machado HL; Montales MT; Pabona JM; Heard ME; Nagarajan S; Simmen RC
Stem Cell Res; 2013 Nov; 11(3):1149-62. PubMed ID: 24012543
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinases play an active role in Wnt1-induced mammary tumorigenesis.
Blavier L; Lazaryev A; Dorey F; Shackleford GM; DeClerck YA
Cancer Res; 2006 Mar; 66(5):2691-9. PubMed ID: 16510589
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of inhibition of MMTV-neu and MMTV-wnt1 induced mammary oncogenesis by RARalpha agonist AM580.
Lu Y; Bertran S; Samuels TA; Mira-y-Lopez R; Farias EF
Oncogene; 2010 Jun; 29(25):3665-76. PubMed ID: 20453882
[TBL] [Abstract][Full Text] [Related]
10. MMTV-Wnt1 and -DeltaN89beta-catenin induce canonical signaling in distinct progenitors and differentially activate Hedgehog signaling within mammary tumors.
Teissedre B; Pinderhughes A; Incassati A; Hatsell SJ; Hiremath M; Cowin P
PLoS One; 2009; 4(2):e4537. PubMed ID: 19225568
[TBL] [Abstract][Full Text] [Related]
11. Inactivation of RARβ inhibits Wnt1-induced mammary tumorigenesis by suppressing epithelial-mesenchymal transitions.
Liu X; Giguère V
Nucl Recept Signal; 2014; 12():e004. PubMed ID: 25422594
[TBL] [Abstract][Full Text] [Related]
12. Reversal by RARα agonist Am580 of c-Myc-induced imbalance in RARα/RARγ expression during MMTV-Myc tumorigenesis.
Bosch A; Bertran SP; Lu Y; Garcia A; Jones AM; Dawson MI; Farias EF
Breast Cancer Res; 2012 Aug; 14(4):R121. PubMed ID: 22920668
[TBL] [Abstract][Full Text] [Related]
13. A mouse mammary tumor virus-Wnt-1 transgene induces mammary gland hyperplasia and tumorigenesis in mice lacking estrogen receptor-alpha.
Bocchinfuso WP; Hively WP; Couse JF; Varmus HE; Korach KS
Cancer Res; 1999 Apr; 59(8):1869-76. PubMed ID: 10213494
[TBL] [Abstract][Full Text] [Related]
14. The MMTV-Wnt1 murine model produces two phenotypically distinct subtypes of mammary tumors with unique therapeutic responses to an EGFR inhibitor.
Pfefferle AD; Darr DB; Calhoun BC; Mott KR; Rosen JM; Perou CM
Dis Model Mech; 2019 Jul; 12(7):. PubMed ID: 31213486
[TBL] [Abstract][Full Text] [Related]
15. Mammary Precancerous Stem and Non-Stem Cells Evolve into Cancers of Distinct Subtypes.
Bu W; Liu Z; Jiang W; Nagi C; Huang S; Edwards DP; Jo E; Mo Q; Creighton CJ; Hilsenbeck SG; Leavitt AD; Lewis MT; Wong STC; Li Y
Cancer Res; 2019 Jan; 79(1):61-71. PubMed ID: 30401712
[TBL] [Abstract][Full Text] [Related]
16. Wnt5a suppresses tumor formation and redirects tumor phenotype in MMTV-Wnt1 tumors.
Easter SL; Mitchell EH; Baxley SE; Desmond R; Frost AR; Serra R
PLoS One; 2014; 9(11):e113247. PubMed ID: 25401739
[TBL] [Abstract][Full Text] [Related]
17. Evidence for a multipotent mammary progenitor with pregnancy-specific activity.
Kaanta AS; Virtanen C; Selfors LM; Brugge JS; Neel BG
Breast Cancer Res; 2013; 15(4):R65. PubMed ID: 23947835
[TBL] [Abstract][Full Text] [Related]
18. IGF1R inhibition in mammary epithelia promotes canonical Wnt signaling and Wnt1-driven tumors.
Rota LM; Albanito L; Shin ME; Goyeneche CL; Shushanov S; Gallagher EJ; LeRoith D; Lazzarino DA; Wood TL
Cancer Res; 2014 Oct; 74(19):5668-79. PubMed ID: 25092896
[TBL] [Abstract][Full Text] [Related]
19. Wnt signaling activation and mammary gland hyperplasia in MMTV-LRP6 transgenic mice: implication for breast cancer tumorigenesis.
Zhang J; Li Y; Liu Q; Lu W; Bu G
Oncogene; 2010 Jan; 29(4):539-49. PubMed ID: 19881541
[TBL] [Abstract][Full Text] [Related]
20. Changes in gene expression during the development of mammary tumors in MMTV-Wnt-1 transgenic mice.
Huang S; Li Y; Chen Y; Podsypanina K; Chamorro M; Olshen AB; Desai KV; Tann A; Petersen D; Green JE; Varmus HE
Genome Biol; 2005; 6(10):R84. PubMed ID: 16207355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
